Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05046080 · ClinicalTrials.gov registry record
Clinicopathologic and Ancillary Testing of Primary Clear Cell Carcinoma of the Cervix
A clinical trial of Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 70
- Enrollment target
- 1
- Study location
NCT05046080 is a study of Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 70 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05046080, a study of Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to provide a comprehensive report on clinicopathologic features, immunohistochemical/biomarker testing and molecular profile of cervical clear cell carcinoma. This study may help researchers learn more about the molecular profile of cervical clear cell carcinoma.
Conditions Studied
Interventions
- OTHER Laboratory Biomarker Analysis
- OTHER Electronic Health Record Review
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2021-08-06 |
| Est. Completion | 2026-09-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05046080
The ClinicalTrials.gov registry entry for NCT05046080 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type appearing as the primary indexed condition, and to 2 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT05046080 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05046080 about?
NCT05046080 is a clinical study titled "Clinicopathologic and Ancillary Testing of Primary Clear Cell Carcinoma of the Cervix". This study aims to provide a comprehensive report on clinicopathologic features, immunohistochemical/biomarker testing and molecular profile of cervical clear cell carcinoma. This study may help researchers learn more about the molecular profile of cervical clear cell carcinoma.
What is the current status of trial NCT05046080?
This trial is currently recruiting. The enrollment target is 70 participants. The study started on 2021-08-06. Estimated completion is 2026-09-29.
What conditions does trial NCT05046080 study?
This clinical trial studies the following conditions: Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type.
What interventions are being tested in trial NCT05046080?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Electronic Health Record Review (OTHER).
Who is sponsoring clinical trial NCT05046080?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05046080 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.